Dietrich Christoph Frank, Annema Jouke Tabe, Clementsen Paul, Cui Xin Wu, Borst Mathias Maximilian, Jenssen Christian
1 Medical Department 2, Caritas-Krankenhaus Bad Mergentheim, Academic Teaching Hospital of the University of Würzburg, Würzburg, Germany ; 2 Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands ; 3 Department of Pulmonary Medicine, Gentofte University Hospital, Denmark and Centre for Clinical Education, Rigshospitalet, University of Copenhagen and the Capital Region of Denmark, Hellerup, Denmark ; 4 Medical Department 1, Caritas-Krankenhaus Bad Mergentheim, Academic Teaching Hospital of the University of Würzburg, Würzburg, Germany ; 5 Department of Internal Medicine, Krankenhaus Märkisch Oderland, Strausberg/Wriezen, Germany.
J Thorac Dis. 2015 Sep;7(9):E311-25. doi: 10.3978/j.issn.2072-1439.2015.09.40.
Ultrasound imaging has gained importance in pulmonary medicine over the last decades including conventional transcutaneous ultrasound (TUS), endoscopic ultrasound (EUS), and endobronchial ultrasound (EBUS). Mediastinal lymph node staging affects the management of patients with both operable and inoperable lung cancer (e.g., surgery vs. combined chemoradiation therapy). Tissue sampling is often indicated for accurate nodal staging. Recent international lung cancer staging guidelines clearly state that endosonography (EUS and EBUS) should be the initial tissue sampling test over surgical staging. Mediastinal nodes can be sampled from the airways [EBUS combined with transbronchial needle aspiration (EBUS-TBNA)] or the esophagus [EUS fine needle aspiration (EUS-FNA)]. EBUS and EUS have a complementary diagnostic yield and in combination virtually all mediastinal lymph nodes can be biopsied. Additionally endosonography has an excellent yield in assessing granulomas in patients suspected of sarcoidosis. The aim of this review, in two integrative parts, is to discuss the current role and future perspectives of all ultrasound techniques available for the evaluation of mediastinal lymphadenopathy and mediastinal staging of lung cancer. A specific emphasis will be on learning mediastinal endosonography. Part I is dealing with an introduction into ultrasound techniques, mediastinal lymph node anatomy and diagnostic reach of ultrasound techniques and part II with the clinical work up of neoplastic and inflammatory mediastinal lymphadenopathy using ultrasound techniques and how to learn mediastinal endosonography.
在过去几十年中,超声成像在肺部医学领域愈发重要,包括传统经皮超声(TUS)、内镜超声(EUS)和支气管内超声(EBUS)。纵隔淋巴结分期影响可手术和不可手术肺癌患者的治疗管理(例如,手术与放化疗联合治疗)。组织采样常用于准确的淋巴结分期。近期国际肺癌分期指南明确指出,相对于手术分期,内镜超声检查(EUS和EBUS)应作为初始组织采样检查。纵隔淋巴结可从气道[EBUS联合经支气管针吸活检(EBUS-TBNA)]或食管[EUS细针穿刺抽吸活检(EUS-FNA)]进行采样。EBUS和EUS具有互补的诊断率,联合使用几乎可以对所有纵隔淋巴结进行活检。此外,内镜超声检查在评估疑似结节病患者的肉芽肿方面具有很高的诊断率。本综述分为两个综合部分,旨在讨论所有可用于评估纵隔淋巴结病和肺癌纵隔分期的超声技术的当前作用和未来前景。将特别强调学习纵隔内镜超声检查。第一部分介绍超声技术、纵隔淋巴结解剖结构以及超声技术的诊断范围,第二部分介绍使用超声技术对肿瘤性和炎性纵隔淋巴结病进行临床检查以及如何学习纵隔内镜超声检查。